Sarah Attia and her husband Ivan getting ready for a round of IVF
Sarah Attia always knew she wanted to be a mom. What she didn’t know was how long, difficult, exhausting and expensive her pregnancy journey would be. Despite her certainty, she says “I also had this feeling pretty early on that we were going to have a hard time.”
In November of that year, Sarah and Ivan did their first embryo transfer. It failed. Sarah was devastated. “We had friends who got pregnant after their first transfer, and I naively thought it would be the same for us.” That’s when Sarah started joining online fertility support groups for women and couples. “My mom and my best friend were great, but they couldn’t really understand what I was going through.” It felt good to connect with people, even online, who were in the same “lousy club,” particularly at a time when the outside world felt so isolated.They transferred their final embryo in September 2020, and that one failed too.
On the day of the transfer—their tenth in all—Sarah remembers feeling intense pressure, given everything they’d gone through to get there. “I was sobbing in the chair,” she says. The transfer failed. Sarah finally felt like she was finished with IVF. They had embryos left from their latest retrieval, but she just wanted to get to whatever was next—surrogacy or adoption, both of which she’d been actively exploring—on their journey to creating a family.
IVF TTC Experimental Immunotherapy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Scientists pioneer immunotherapy technique for autoimmune diseasesScientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases.
Read more »
'Quad Shot' Radiation Plus Immunotherapy Improves Local Control in Head, Neck CancerA palliative Quad Shot radiotherapy regimen alongside concurrent immunotherapy can improve local control in symptomatic patients with head and neck cancer but may not improve overall survival.
Read more »
Groundbreaking immunotherapy shrinks aggressive brain tumor in new trialA groundbreaking clinical trial has demonstrated the potential of CAR T-cell therapy to shrink aggressive brain tumors.
Read more »
Subcutaneous Immunotherapy: Better Life for Patients With CancerAdministering immunotherapy via subcutaneous infections could save clinicians time and money and patients may prefer it.
Read more »
Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapyPurdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.
Read more »
New immunotherapy could make blood more 'youthful,' mouse study hintsEmily is a health news writer based in London, United Kingdom. She holds a bachelor's degree in biology from Durham University and a master's degree in clinical and therapeutic neuroscience from Oxford University. She has worked in science communication, medical writing and as a local news reporter while undertaking journalism training.
Read more »